comparemela.com

Page 13 - இணை ஆணையர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chembio Diagnostics Appoints David Acheson, M D to its Board of Directors

Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors HAUPPAUGE, N.Y., Dec. 17, 2020 Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors. “We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his perspective will contribute meaningfully to our long-term value creation strategy,” said Katherine L. Davis, Chair of Chembio’s Board of Directors. “We look forward to his leadership and insights as we enter the next phase of growth for Chembio.”

SBC Commish Keith Gill On How The Sun Belt Has Promoted Itself

In his first media session as Sun Belt Conference commissioner, Keith Gill said, We need to do a better job of telling our story. That was in July of 2019 during his state of the conference address at Sun Belt Conference Media Day. Fast forward 17 months, and the 2020 Sun Belt Conference Championship game features two teams ranked in the top 17 of the AP poll, as #9 Coastal Carolina (11-0) hosts #17 Louisiana (9-1). The Sun Belt has experienced unprecedented success in 2020. Has the conference done a good job telling their story? Gill was available via teleconference yesterday as part of SBC championship week.

Big Rock Partners Acquisition Corp Announces Merger with NeuroRx, Inc

Big Rock Partners Acquisition Corp Announces Merger with NeuroRx, Inc
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

PathogenDx Appoints Dr David Acheson as a Strategic Advisor to Chair Its New Food Safety Committee

Share: SCOTTSDALE, Ariz., Dec. 14, 2020 /PRNewswire/  PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today that Dr. David Acheson will join the company as a strategic advisor. As part of the role, Dr. Acheson will form a food safety committee that will inform the company s development of rapid detection testing technologies for the food industry. Dr. Acheson brings more than 35 years of medical and food safety research and experience to PathogenDx. Formally trained in internal medicine and infectious diseases, he left his practice to teach and study at Tufts University in Boston, where he researched the molecular pathogenesis of foodborne pathogens. Subsequently, he was tapped to serve as Chief Medical Officer at both the USDA Food Safety and Inspection Service as well as the U.S. Food and Drug Administration at the Center for Food Safety and Applied Nutrition (CFSAN), and was later

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.